Proven Site Strategies: Accelerating Startup, Recruitment, and Retention in Dermatology Clinical Trials
Clinical trials are the engine of medical progress, yet in dermatology, their velocity is often hindered by operational friction. While […]
Accelerating Enrollment in a Phase 2b Atopic Dermatitis Study
Study Objectives Enrollment of 250 participants, across 100 sites, study wide Alliance Clinical Network Goal: Enroll 10 participants in 6
Exceeding Enrollment Goals in a Phase 3 Severe Hypertriglyceridemia Study
Study Objectives Study enrollment goal of 300 participants across 140 sites, across 17 countries. Alliance Clinical Network Goal: Enroll 1
Delivering on Diversity in a Phase 2b Diabetic Peripheral Neuropathy Study
Study Objectives Enrollment of 416 participants, across 100 sites, study wide Alliance Clinical Network Goal: Enroll 10 participants ChallengesDuring the
How eSource Empowers Clinical Sites to Perform at Their Best
As clinical studies become more complex and timelines contract, clinical research sites face pressure to deliver high-quality data, remain compliant,
5 Keys to Maximizing Patient Recruitment and Retention in Dermatology Clinical Trials
Skin conditions are among the most common health issues worldwide, increasing the demand for effective, long-lasting treatments. In the US,
Streamlining Recruitment in a Phase 3 Pulmonary Study
Study Objectives Competitive enrollment of 5,000 participants across multiple sites, within a 48-month enrollment window. Alliance Clinical Network Goal: Enroll
Site-Level Strategies to Drive Better Clinical Research Outcomes in Type 2 Diabetes Trials
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are
History of GLP-1 Approvals in the U.S.
The following table provides a brief history of GLP-1 therapies that have received FDA regulatory approval. In addition to identifying brand name,
Successful Site Performance in a Phase 2b Influenza Prevention Study
Study Objectives Enroll 4,000 participants across multiple global sites. Alliance Clinical Network Goal: Enroll 300 participants (150 per site) within